US ‘gag rule’ leads to 90,000 additional HIV infections annually
Generic PrEP for young, at-risk MSM in the US could be cost-saving and health-enhancing
Voluntary licensing via the Medicines Patent Pool is saving hundreds of thousands of lives
Fund the HIV Action Plan
Equity in HIV funding: the right thing to do, cheaper, and more effective
Getting to 95-95-95: global use of HIV generics would result in large reductions in spending, new infections and deaths
Who’s financing the ‘anti-gender’ movement in Europe?
Injectable HIV therapy would have to cost less than $131 a year to be cost-effective in Africa
To be cost-effective, injectable PrEP can only cost about $3000 more than US generic oral PrEP
